Literature DB >> 12707221

Clinical consequences of iron overload in hemochromatosis homozygotes.

Richard S Ajioka1, James P Kushner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707221     DOI: 10.1182/blood-2002-11-3453

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

Review 1.  Systems genetics of mineral metabolism.

Authors:  James C Fleet; Rebecca Replogle; David E Salt
Journal:  J Nutr       Date:  2011-01-26       Impact factor: 4.798

2.  Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients.

Authors:  C A McCune; D Ravine; K Carter; H A Jackson; D Hutton; J Hedderich; M Krawczak; M Worwood
Journal:  Gut       Date:  2005-09-20       Impact factor: 23.059

3.  Iron dysregulation combined with aging prevents sepsis-induced apoptosis.

Authors:  Pardis Javadi; Timothy G Buchman; Paul E Stromberg; Isaiah R Turnbull; Dinesh Vyas; Richard S Hotchkiss; Irene E Karl; Craig M Coopersmith
Journal:  J Surg Res       Date:  2005-09       Impact factor: 2.192

4.  Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?

Authors:  E Cadet; D Capron; M Gallet; M-L Omanga-Léké; H Boutignon; C Julier; K J H Robson; J Rochette
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

5.  Hereditary hemochromatosis restores the virulence of plague vaccine strains.

Authors:  Lauriane E Quenee; Timothy M Hermanas; Nancy Ciletti; Helene Louvel; Nathan C Miller; Derek Elli; Bill Blaylock; Anthony Mitchell; Jay Schroeder; Thomas Krausz; Joseph Kanabrocki; Olaf Schneewind
Journal:  J Infect Dis       Date:  2012-08-14       Impact factor: 5.226

6.  HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  James S Pankow; Eric Boerwinkle; Paul C Adams; Eliseo Guallar; Catherine Leiendecker-Foster; Jason Rogowski; John H Eckfeldt
Journal:  Transl Res       Date:  2008-06-13       Impact factor: 7.012

7.  Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening.

Authors:  Gordon D McLaren; Christine E McLaren; Paul C Adams; James C Barton; David M Reboussin; Victor R Gordeuk; Ronald T Acton; Emily L Harris; Mark R Speechley; Phyliss Sholinsky; Fitzroy W Dawkins; Beverly M Snively; Thomas M Vogt; John H Eckfeldt
Journal:  Can J Gastroenterol       Date:  2008-11       Impact factor: 3.522

8.  Effects of hemochromatosis and transferrin gene mutations on peripheral iron dyshomeostasis in mild cognitive impairment and Alzheimer's and Parkinson's diseases.

Authors:  S Mariani; M Ventriglia; I Simonelli; G Spalletta; S Bucossi; M Siotto; F Assogna; J M Melgari; F Vernieri; R Squitti
Journal:  Front Aging Neurosci       Date:  2013-08-05       Impact factor: 5.750

Review 9.  Genetic mechanisms and modifying factors in hereditary hemochromatosis.

Authors:  Günter Weiss
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11-17       Impact factor: 46.802

Review 10.  How mammals acquire and distribute iron needed for oxygen-based metabolism.

Authors:  Tracey A Rouault
Journal:  PLoS Biol       Date:  2003-12-22       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.